Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a…
Amit Mookim, CEO, Immuneel Therapeutics urges the govt to focus on establishing a strong compliance framework and expediting…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Amit Mookim
Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma
Immuneel has collaborated with hospitals including Narayana Health, Apollo Hospitals, CMC Vellore, Manipal Hospitals among others…
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval…
Industry leaders share their expectations from the upcoming Union budget 2025-26. Increased allocation for R&D and…
Innovation, partnerships and best practices: Priorities for biopharma in 2025
Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth
Immuneel Therapeutics welcomes Amit Mookim as CEO
Mookim will focus on establishing partnerships with providers, practitioners, and public health, and delivering current CART…
OPPI facilitates a panel discussion on National IPR Policy
It focused on interpreting the role of the policy in fostering a culture of innovation
As part of its Golden Jubilee Celebration…